- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03622996
Noncontact Vital Sign Monitoring Using IR-UWB Radar
Noncontact Vital Sign Monitoring Using Impulse Radio Ultra-wideband (IR-UWB) Radar in Neonates and Children
Background: Contact sensors can cause injuries and infections in newborn infants with fragile skin. The impulse radio ultra-wideband (IR-UWB) radar is recently demonstrated in adults as a contactless method to measure heart rate. The purpose of this study is to assess heart rate (HR) in neonates using IR-UWB radar and evaluate its accuracy, compared to the electrocardiogram (ECG) in the neonatal intensive care unit (NICU).
Methods: HR is recorded in newborn infants using both IR-UWB radar 35 cm away from the chest and ECG simultaneously in the NICU. The HR data during sleeping/calm state are automatically collected by a software algorithm. A total values averaged from a 30-second window every 10 s is used for the analysis. Data acquired on the same patient with standard electrocardiogram has been used for comparison.
Study Overview
Status
Conditions
Detailed Description
Vital sign is recorded by the radar and bedside ECG simultaneously in supine position within an open-air crib.
The three electrodes of the ECG are attached at the standard positions and connected to the BSM-6501K patient monitor (Nihon Kohden, Tokyo, Japan), and vital signs are recorded and extracted.
The data from the radar is connected to a computer through a USB interface, and signal processing has been automatically performed by a software algorithm described by our previous study. A Fourier transform decomposes a signal with respect to time into a frequency component.
Vital sign is recorded continuously, and digital outputs are extracted from periods when no large noise or fluctuation occurs in both methods. While vital sign acquisition is significantly interfered with moving extensively, being in nursing care, repetitive myoclonus, hiccupping, flopping, or crying, the IR-UWB radar system stops the measurements and deletes the motion-contaminated observations automatically by itself. To investigate the artifact and interference by body movement during measurement, the level of movement is integrated based on the change of distance of the body from the radar. The radar transmits dozens of these signals (frames) to the computer every second, and the frame would not be changed if there was no movement within the range of the radar. However, if there is any movement, the difference of two frames (previous - current) is calculated.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Seoul, Korea, Republic of, 04763
- Recruiting
- Hanyang University College of Medicine
-
Contact:
- Hyun-Kyung Park, Prof
- Phone Number: 82-2-01-4749-1454
- Email: neopark@hanyang.ac.kr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- full-term neonates (> 37 weeks of gestational age)
Exclusion Criteria:
- patients with congenital anomalies
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Detection rate (total time of successful detection/total measurement time) between the IR-UWB radar and conventional monitor for HR and RR measurement
Time Frame: newborns (≥ 37 weeks gestational age) who are admitted in NICU within 28 days of birth (breathing without any respiratory/oxygen support)
|
to assess the potential of IR-UWB radar for monitoring vital signs in neonates, compared to the gold standard monitoring in the NICU
|
newborns (≥ 37 weeks gestational age) who are admitted in NICU within 28 days of birth (breathing without any respiratory/oxygen support)
|
|
Correlation by Pearson coefficient between the IR-UWB radar and conventional monitor for HR and RR measurement
Time Frame: newborns (≥ 37 weeks gestational age) who are admitted in NICU within 28 days of birth (breathing without any respiratory/oxygen support)
|
to evaluate accuracy of IR-UWB radar for monitoring vital signs in neonates, compared to the gold standard monitoring in the NICU
|
newborns (≥ 37 weeks gestational age) who are admitted in NICU within 28 days of birth (breathing without any respiratory/oxygen support)
|
|
Mean difference by Bland-Altman analysis between the IR-UWB radar and conventional monitor for HR and RR measurement
Time Frame: newborns (≥ 37 weeks gestational age) who are admitted in NICU within 28 days of birth (breathing without any respiratory/oxygen support)
|
to evaluate accuracy of IR-UWB radar for monitoring vital signs in neonates, compared to the gold standard monitoring in the NICU
|
newborns (≥ 37 weeks gestational age) who are admitted in NICU within 28 days of birth (breathing without any respiratory/oxygen support)
|
|
Signal matching (%), defined bpm difference ≤ 5, between the IR-UWB radar and conventional monitor for HR measurement
Time Frame: newborns (≥ 37 weeks gestational age) who are admitted in NICU within 28 days of birth (breathing without any respiratory/oxygen support)
|
to evaluate accuracy of IR-UWB radar for monitoring heart rate in neonates, compared to the gold standard monitoring in the NICU
|
newborns (≥ 37 weeks gestational age) who are admitted in NICU within 28 days of birth (breathing without any respiratory/oxygen support)
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: JH Ahn, Hanyang University, Seoul, Korea
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- NRF-2017M3A9E2064735
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on NICU
-
Kahramanmaras Sutcu Imam UniversityRecruitingNICU | Family Centered Care | NICU Infants | Infants Admitted to Neonatal UnitsTurkey (Türkiye)
-
T.C. ORDU ÜNİVERSİTESİCompleted
-
Bnai Zion Medical CenterCompleted
-
Children's Hospital Medical Center, CincinnatiCompleted
-
University of North Carolina, Chapel HillFoundation for Physical Therapy ResearchRecruitingPhysical Therapy | NICU InfantsUnited States
-
Children's Hospital Medical Center, CincinnatiCompletedSafety of a Customized NICU MRI SystemUnited States
-
Meir Medical CenterUnknownAdmission to the NICU and Need for Physiological Monitoring.Israel
-
Duke UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...Not yet recruitingPreterm Neonates | NICU | Safety and Pharmacokinetics | Ampicillin | Early Onset SepsisUnited States
-
Women and Infants Hospital of Rhode IslandRecruitingInfant Admitted to Neonatal Intensive Care Unit (NICU) | Doula SupportUnited States
-
Bnai Zion Medical CenterCarmel Medical CenterCompletedInfants in NICU Ventilated With HFVIsrael